Boston Scientific Receives FDA Clearance, CE Mark Approval for Direxion Torqueable Microcatheter

Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation (NYSE: BSX ) has received U.S. Food and Drug Administration clearance and CE Mark approval for its Direxion™ Torqueable Microcatheter. Peripheral embolization is a technique used primarily by interventional radiologists to treat liver cancer, uterine fibroids and